1105. The Burden of Infections Prior to Chimeric Antigen Receptor (CAR) Modified T-cell Therapy Predicts Post-CAR T-cell Infectious Complications

BACKGROUND: CAR T -cell therapy (CTT) is a novel treatment for B-cell cancers. CTT patients (pt) are at risk of infection due to neutropenia, cytokine release syndrome (CRS), and CAR T-cell related encephalopathy syndrome (CRES), which are treated with steroids and tocilizumab (anti-IL-6). This is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Garner, Will, Samanta, Palash, Dorritie, Kathleen, Sehgal, Alison, Winfield, Denise, Agha, Mounzer, Boudreau, Robert, Nguyen, Minh Hong T, Haidar, Ghady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776724/
http://dx.doi.org/10.1093/ofid/ofaa439.1291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776724/
http://dx.doi.org/10.1093/ofid/ofaa439.1291

Ejemplares similares